Kevin Lee, Chief Executive Officer at BICYCLE THERAPEUTICS plc (BCYC), sold 59,170 shares at $38.08 ($2.2M) on 2021-09-01, disclosed to the SEC on 2021-09-03.
Open-market sale of $2.2M BCYC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.38 | 8,191 | $298K | 13.4% |
| 2 | $36.38 | 8,191 | $298K | 13.4% |
| 3 | $37.52 | 17,098 | $642K | 29.0% |
| 4 | $37.52 | 17,098 | $642K | 29.0% |
| 5 | $38.08 | 1,796 | $68K | 3.1% |
| 6 | $38.08 | 1,796 |
| $68K |
| 3.1% |
| 7 | $40.00 | 5,000 | $200K | 9.0% |
| Total | $37.45 avg | 59,170 | $2.2M | 100% |
| Filing → |
| BCYC | SELL | 2026-04-06 | $38K | — | Filing → |
| BCYC | SELL | 2026-01-06 | $141K | — | Filing → |
| BCYC | SELL | 2025-10-06 | $46K | — | Filing → |